Meningeal Carcinomatosis — Trials

Meningeal Carcinomatosis — Trials · CancerIndex

Clinical trials

Registered studies

59 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 28
Recruiting: 12
Ph III recruiting: 0
Growth YoY: —
Industry share: 7%
Top sponsor: Guangzhou Medical University
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (5)

clinicaltrialsPublishedShowing 1–6 of 6 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07833657	Combined Intrathecal and Systemic Therapy With Trastuzumab Rezetecan for Leptomeningeal Metastases(ITST-ADC-LM)	not yet recruiting	Phase 2	28	Jiuda ZhaoOTHER	1	Sep 22, 2026	clinicaltrials
NCT07778940	Thiotepa Administration Via Ommaya Reservoir for Leptomeningeal Metastases in Non-Small Cell Lung Cancer Resistant to EGFR-TKI.(LEP-THP-2026)	not yet recruiting	Phase 2	50	Tianjin Medical University Cancer Institute and HospitalOTHER